Most Read Articles
Jairia Dela Cruz, 6 days ago
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, Yesterday
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
2 days ago
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.
06 Sep 2020
Type 2 diabetes mellitus patients taking proton pump inhibitors (PPIs) are at a higher risk of sustaining hip fractures, a recent study has found.

Prolonged oestrogen exposure in older women yields cognitive benefits

11 Nov 2019

Older women with longer endogenous oestrogen exposure and hormone therapy use are at much higher odds of having favourable cognitive status in late life, a recent study suggests.

Researchers looked at 2,114 dementia-free women (mean age, 74.94 years) at baseline who were enrolled in a 12-year population-based study in Cache County, Utah, US. All women completed a women's health questionnaire, which detailed reproductive history and hormone therapy use. They also underwent cognitive status assessment using a modified version of the Mini-Mental State Examination (3MS) at four triennial waves.

Researchers calculated endogenous oestrogen exposure by taking the reproductive window (age at menarche to age at menopause) and adjusting for pregnancy and breastfeeding. Hormone therapy variables included duration of use, type (unopposed and opposed) and time of initiation.

There was a positive association between endogenous oestrogen exposure and cognitive status (p=0.054). The same was true for longer duration of hormone therapy use (p=0.046), but exerting a major impact on age, such that older women obtained greater benefit compared with their younger counterparts.

The timing of hormone therapy initiation showed a significant association with 3MS (p=0.048). Specifically, higher 3MS scores were observed in women who initiated therapy within 5 years of menopause than in those initiating therapy 6 years later.

Possessing potent antioxidant properties, oestrogens play important roles in maintaining normal reproductive and nonreproductive functions. These hormones exert neuroprotective actions and their loss during ageing, and their loss has been suggested to promote an accelerated ageing phenotype eventually leading to the development of brain hypometabolism, a feature commonly observed in menopausal women and prodromal Alzheimer’s disease. [Front Aging Neurosci 2017;9:430]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 6 days ago
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, Yesterday
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
2 days ago
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.
06 Sep 2020
Type 2 diabetes mellitus patients taking proton pump inhibitors (PPIs) are at a higher risk of sustaining hip fractures, a recent study has found.